TechCrunch+ roundup: Non-dilutive biotech capital, long-term angel investing, WayRay’s $80M pitch deck
TechCrunch
JUNE 24, 2022
Alomar, who led startups through the dotcom bust of 2000 and the Great Recession of 2008, will talk about whether investors are still prioritizing growth over profits, and identify which proof points founding teams must define before their next raise. 3 tips for biotech startups seeking non-dilutive capital to weather the downturn.
Let's personalize your content